The development status of peptide drugs

- Aug 19, 2019-

Peptide drugs are primarily used to treat major diseases related to cancer and metabolic disorders, which have a very important global market. Currently, there are about 60 to 70 peptide drugs in the global drug market, such as somatuline, copaxone, zoladex, sandostatin, secretin, leuprolide, icatibant, ceruletide , bivalirudin, vasopressin, vapreotide, pramlintide, corticotropin and bacitracin, etc., there are 200 to 300 peptide drugs in clinical trials, 500 to 600 drugs are being tested in preclinical trials, and more peptide drugs are in the laboratory research phase.